Organization
Daiichi Sankyo Co Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Daiichi Sankyo Co Ltd.
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), today announced results of a sub-analysis from ...
... Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced it will present data on ...
... investors, as well as advisors, to attend interactive, real-time virtual event Daiichi Sankyo Co., Ltd. (JP: 4568.T, OTC: DSNKY) based in Tokyo, Japan and focused ...
... candidates developed using our Azymetric(TM) bispecific platform. Recent successes by Merck and Daiichi Sankyo further validate the value of our technology platform for developing next-generation ...
... any given combination including COTELLIC. Corporate Highlights Updates from Partnered Programs with Daiichi Sankyo and BMS. In the third quarter and shortly after the quarter ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the Board of Directors approved a resolution on ...
... AstraZeneca Aurigene Discovery Technologies Bristol-Myers Squibb CoStim Pharmaceuticals CureTech Ltd Curis Inc Daiichi Sankyo Dako (subsidiary of Agilent Technologies) DMC (Data Monitoring Committee) Dynavax GlaxoSmithKline ...
... any given combination including COTELLIC. Corporate Highlights Updates from Partnered Programs with Daiichi Sankyo and BMS. In the third quarter and shortly after the quarter ...
... Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the pivotal phase 3 ...
... A year ago, we reported that Japanese pharma Daiichi Sankyo and partner Plexxikon had suspended a trial of its rare cancer ...
... today a program with global pharmaceutical company Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) focused on using the Beacon platform to accelerate its cell line ...
... Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have signed ...
... Daiichi Sankyo has teamed up with Glycotope to develop an antibody-drug conjugate with ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo) announced today that the research that it is jointly conducting with ...
... Cancer Center), JVCKENWOOD Corporation (hereafter, JVCKENWOOD), Sysmex Corporation (hereafter, Sysmex) and Daiichi Sankyo Company Limited (hereafter, Daiichi Sankyo) announced today that they have commenced collaborative ...
... Tokyo, Japan - Daiichi Sankyo, Company Limited (hereafter Daiichi Sankyo) announced today that its development of ...
... Sankyo Company, Limited (President and COO: Sunao Manabe; Headquarters: Tokyo; TSE: 4568; 'Daiichi Sankyo' ) today announced that the companies will jointly conduct a program ...
... available in the market: - vTv Therapeutics - TauRx - Novartis - Daiichi Sankyo - Lundbeck - Actavis - Eisai - Pfizer · Profiles of ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has underwritten all shares issued by its ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced details of the application for its Take a New ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the primary endpoint has been achieved from ESAX-HTN ...
... With a positive phase 3 trial in hand, Japan’s Daiichi Sankyo plans to file its essential hypertension therapy esaxerenone in its home ...
... with essential hypertension in Japan. With the trial achieving its primary endpoint, Daiichi Sankyo has communicated its intention to submit a Japanese regulatory application for ...
... Tokyo, Japan - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has been listed ...
... The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced a multi-year collaboration focused on ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤